这时，三分之一的候选药物通不过这个试验。
At the moment, a third of drug candidates do not pass such trials.
NRGN可能是一种候选药物靶标，因为它显然在调控记忆和认知方面很重要，这些过程常常在精神分裂症中被扰乱。
NRGN may be a candidate drug target, as it appears to play an important role in regulating both memory and cognition, processes that are often perturbed in schizophrenics.
应用推荐